- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 209/10 - Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
Patent holdings for IPC class C07D 209/10
Total number of patents in this class: 303
10-year publication summary
|
23
|
26
|
31
|
23
|
30
|
24
|
19
|
14
|
13
|
3
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4629 |
7 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 269 |
6 |
| Board of Regents, The University of Texas System | 5370 |
6 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
6 |
| Emory University | 1498 |
5 |
| Nanoquantum Sciences, Inc. | 6 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
5 |
| Merck Sharp & Dohme LLC | 3689 |
5 |
| Merck Patent GmbH | 5909 |
4 |
| Dyomics GmbH | 21 |
4 |
| Oxagen Limited | 10 |
4 |
| Pharmaxis Ltd | 43 |
4 |
| Pierce Biotechnology, Inc. | 132 |
4 |
| Symed Labs Limited | 54 |
4 |
| New Mexico Tech University Research Park Corporation | 35 |
4 |
| Recurium IP Holdings, LLC | 138 |
4 |
| Novartis AG | 11238 |
3 |
| Bristol-myers Squibb Company | 5080 |
3 |
| F. Hoffmann-La Roche AG | 7958 |
3 |
| The Regents of the University of California | 18943 |
3 |
| Other owners | 214 |